High-throughput binding characterization of bacterial transcription factors by Iazzetti, Paul Christopher
Boston University
OpenBU http://open.bu.edu








COLLEGE OF ENGINEERING 
Dissertation 
HIGH-THROUGHPUT BINDING CHARACTERIZATION OF BACTERIAL 
TRANSCRIPTION FACTORS 
by 
PAUL CHRISTOPHER IAZZETTI 
B.S., University of Virginia, 2009 
M.S., Boston University, 2013 
Submitted in partial fulfillment of the 
requirements for the degree of 
Doctor of Philosophy 
2014 
© 2014 by 
Paul Christopher lazzetti 
All rights reserved 
Approved by 
First Reader 
Jgme-s·'~- Galagan, Ph.D. 
~ssociate Professor of Biomedical Engineering 
Associate Professor of Microbiology 
Second Reader 
Igor Kramnik, M.D., Ph.D. 
Associate Professor of Medicine 
Third Reader 
Fourth Reader 
Wilson W. Wong, Ph.D. 
Assistant Professor of Biomedical Engineering 
DEDICATION 
For my parents, Armando and Barbara, whose love and support over the years 
has shaped me into who I am today. 
iv 
ACKNOWLEDGMENTS 
I would like to thank my friends and family for their support during this 
experience. I would particularly like to thank Kelli, whose amazing support, 
encouragement, love, and faith in me helped me make it to the finish line. I do 
not know what I would do without her. 
v 
HIGH-THROUGHPUT BINDING CHARACTERIZATION OF BACTERIAL 
· TRANSCRIPTION FACTORS 
PAUL CHRISTOPHER IAZZETTI 
Boston University College of Engineering, 2014 
Major Professor: James Galagan, Professor of Biomedical Engineering 
ABSTRACT 
Tuberculosis (TB) is a global pandemic responsible for the deaths of 1.5 million 
people annually. A third of the world's population is thought to harbor the 
latent form of the disease, and a disproportionate majority of TB cases are 
reported in Asia and Africa where poor infrastructure impedes proper treatment. 
Non-adherence to drug regimens has helped foster the rise of multi 
drug-resistant tuberculosis, with implications for those in the developed world. 
Treatment of the disease is hindered by an inadequate understanding of its 
causative agent, the pathogen Mycobacterium tuberculosis (MTB). Decreases in 
thecost of gene sequencing have heralded a new era of genomic technologies 
such as chromatin immunoprecipitation sequencing (ChiP-Seq), which can 
generate comprehensive in-vivo genomic binding data for transcription factors 
and help elucidate the workings of bacterial regulatory networks. 
In this work we explore the in vitro binding behavior of MTB transcription factors 
important to disease pathogenesis using electrophoretic mobility shift assays 
(EMSAs) and High-Throughput Sequencing- Fluorescent Ligand Interaction 
vi 
Profiling (HiTS-FLIP). We compare this data to high-throughput in vivo binding 
data generated by ChiP-Seq to assessing binding patterns across in vitro and in 
vivo conditions, and demonstrate the use of HiTS-FLIP as a powerful 
complement to ChiP-Seq for accurately characterizing transcription factor binding 
affinity. The results of this work lay the foundation for an integrated experimental 
workflow combining high-throughput in vitro and in vivo transcription factor 
binding data to better understand transcription factor behavior in vivo. 
vii 
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Tuberculosis (TB) is a global pandemic, with an estimated yearly death toll of 1.5 
million people 1. Incidence of the disease is divided between active TB, with 
nearly 9 million annual cases 1, and latent TB, which is estimated to infect a third 
of the world population. A disproportionately high number of TB cases occur in 
underdeveloped regions of the world, notably in Africa and Asia 1·2 , where poor 
infrastructure and limited access to medical care hinder efforts to diagnose TB 
and implement the lengthy treatment regimens necessary to eradicate the 
disease2•3. TB is also the most common individual cause of death in AIDS 
patients2.4, and HIV and TB act cooperatively to enhance each other's 
progression5·6 . Vaccines against TB using an attenuated version of 
Mycobacterium bovis have shown variable and insufficient efficacy in practice7, 
and drugs for active TB cases require unacceptably long treatment periods: 6 
months of combination drug therapy for fully drug-sensitive TB8 , and a minimum 
of 20 months for multi-drug and extensively-drug resistant TB1. There is thus a 
significant need for faster, more effective TB drug treatments. Much of the 
difficulty in treating the disease is due to an inadequate understanding of its 
causative bacterial agent, Mycobacterium tuberculosis (MTB). 
MTB is a rod-shaped, highly adaptive bacterium. Humans are the only natural 
host for MTB, and transmission occurs through inhalation of MTB-containing 
aerosol droplets that have been expelled from a host with active TB, typically 
2 
through coughing or sneezing. Once inhaled, MTB migrates to the alveoli of the 
lung and is engulfed by alveolar macrophages, which create internalized 
phagosomes to surround and isolate the bacteria. Normally macrophages can 
effectively dispose of phagocytosed pathogens, but MTB is able to repurpose the 
macrophage as a reproductive haven through several mechanisms, one of the 
most important being its ability to avoid the lysosome's caustic contents through 
prevention of phagolysosome fusion 9·10. Rendered unable to dispose of the 
pathogen, MTB-infected macrophages release cytokines to recruit other immune 
cells, which surround and eventually contain the infection by creating an 





Figure 1.1 I Granuloma Development11 . MTB is able to reside inside of host 
macrophages. Infected macrophages recruit other immune cells to form an organized 
barrier around the infection known as the granuloma, and MTB can survive in this state 
for years. Reprinted by permission from Macmillan Publishers Ltd : Nature Reviews 
Microbiology, Russell, D. G., Who puts the tubercle in tuberculosis, 40, 200711 . 
Granuloma formation is characteristic of the latent TB disease state, and 
individuals with latent TB are asymptomatic and cannot transmit the disease to 
others. Over time a fibrous cuff forms around the granuloma, interior 
vascularization decreases 1\ and macrophages trapped inside die, resulting in 
the necrotic, caseous center that is the hallmark of the disease 11·12 . MTB can 
survive for years in this environment, and roughly 10% of individuals with latent 
TB will suffer reactivation of TB to an active state if MTB is able to breach the 
granuloma 13 . Several factors can aid in TB reactivation, including increased 
nutrient availability from the liquefaction of dead macrophages in the granuloma 
interior12·14 , malnutrition, old age, and other sickness which depresses immune 
function 11 (co infection with H IV alone elevates the risk of reactivation from 1 0% 
over a lifetime to 5-15% annualli 5). 
3 
By necessity, MTB has evolved to survive inhospitable environments. Much of its 
resiliency is attributed to its unusual cell wall, which consists of two segments: a 
core of mycolic acids, peptidoglycan, and arabinogalactan, and an outer segment 
of free lipids 16·17 . MTB's cell wall is impermeable to hydrophilic solutes due to its 
high lipid content, and its structured composition reduces its fluidity and impedes 
the passage of lipophilic agents 18 . These adaptations enhance survival inside the 
granuloma, where evidence suggests MTB encounters reactive nitric oxide 
species, acidity, hypoxia, and nutrient deprivation 19 . MTB responds to these 
changes by transitioning into a dormant state characterized by decreased 
metabolic activitl0·21 and a switch to a reliance on fatty acids as a carbon 
4 
source22 . The exact combination of stressors needed to cause this transition is 
not fully understood, but hypoxia has been implicated as a dominant inducer of 
MTB latenc/1•23 . The importance offatty acids and cholesterol to MTB survival is 
evidenced by its high proportion of genes involved in fatty acid metabolism24 , the 
observation that MTB is capable of surviving on cholesterol in the absence of 
other carbon sources25·26 , and studies that show disruption of cholesterol 
metabolism is detrimental to MTB virulence26 . 
MTB's success as a pathogen is reliant on its ability to maintain a state of 
dormancy during its time inside the granuloma. There are still large gaps in our 
knowledge of how MTB transitions to this state, and what changes its metabolic 
network undergoes to efficiently metabolize scarce nutrient sources during 
dormanc/7 . Progress in ameliorating these knowledge deficiencies has taken a 
leap in recent years due to advancements in DNA sequencing technologies. 
1.1 DNA Sequencing 
Frederick Sanger developed an efficient sequencing method in 1977 by noting 
that ddNTPs lacking a 3' hydroxyl group halt strand elongation after incorporation 
by DNA polymerase. In his method, regular dNTPs, DNA polymerase, a template 
DNA strand, and a single, homogenous set of ddNTPs (A,G,C or T) are 
combined in four separate reactions to generate DNA strands of varied length 
based on random incorporation of one of the chain terminating ddNTPs28. These 
strands are then size separated on a polyacrylamide gel, visualized via a 
radioactive tag on one of the four dNTPs, and cross referenced across all four 
5 
ddNTP reactions to determine the sequence of the original template strand28 . 
The development of fluorescent reporter dyes specific to each nucleotide in lieu 
of radioactive DNA labels and advances in computing power allowed for the 
implementation of the first automated sequencers in 198629 . Researchers 
capitalized on automated technologies and increased computing power to 
sequence larger DNA constructs through a process of fragmenting DNA 
templates, sequencing one or both of the fragment ends, and computationally 
piecing together fragment overlaps to reconstruct the original DNA sequence. 
This approach, known as shotgun sequencing, allowed for sequencing of entire 
genomes, and was applied by competing teams of researchers in the public and 
private sector to publish the first draft of the human genome in 2001 30·31 . Since 
then both the cost and time requirements for sequencing have dropped 
precipitously. The Human Genome Project was a 13 year, nearly 3 billion dollar 
endeavor32 ; by 2008 the human genome could be sequenced in 2 months at a 
cost of less than 1 million dollars33 and today the same feat can be finished in 
days at a cost measured in the thousands34 . These exponential improvements in 
sequencing performance are a result of next-generation sequencing (NGS) 
technologies, which have supplanted Sanger sequencing's decades-long reign. 
Many different NGS sequencing platforms exist, but lllumina's NGS platforms 
dominate the market due to a balance of throughput, cost, and qualitl5 . lllumina 
employs a proprietary sequencing by synthesis (SBS) method, whereby 
nucleotides with a reversible, uniquely identifiable fluorescent terminator are 
sequentially added to DNA template strands affixed to a flow cell and imaged to 
determine the identity of the incorporated base. After an imaging cycle is 
complete, the terminator is removed and another nucleotide is added, and the 
process repeats until the desired read length is achieved. In this way the 
complement of the strand is built as sequencing progresses (Figure 1.2). 
Depending on the exact system, lllumina's products offer up 250 bp reads, and 
can sequence billions of single or paired-end reads on a single flow cell in a 
matter of days. 
6 
Relegation of sequencing to the role of a common, readily outsourced lab 
technique gives the modern biomedical researcher a powerful tool with which to 
probe the etiologies of human diseases in previously unimaginable detail. 
Although much focus has been given to the ability of NGS to determine the 
variations in our own genes that may give rise to cancers36, autoimmune 
disorders37 , and other ailments, these technologies also play a crucial role in 
furthering our understanding of malignant pathogens that plague our species 
around the globe, including MTB. The complete sequencing of the MTB genome 
in 1998 and the decreased cost of sequencing technologies in general have shed 
light on the genetic mechanisms MTB employs to survive. As a result of these 
advances research interests have shifted towards a systems level approach to 
understanding the complex sets of interactions between genes and their gene 
products responsible for cell behavior and survival, as evidenced through the 
study of gene regulatory networks. 
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Figure 1.2 llllumina Sequencing Workflow 38 . 1 -Adapters are ligated onto the 
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ends of DNA fragments. 2 -Adapter-ligated DNA strands are affixed to the surface of 
the flow cell. 3-6- DNA bridges over to complement its unattached strand (3) , normal 
dNTPs and polymerase are added to create dsDNA (4) , DNA is denatured into single 
strands again (5), and the cycle is repeated to form dense clusters of identical ssDNA 
molecules (6) . 7- Fluorescently-tagged dNTPs and polymerase are added to from a 
complementary DNA strand one base pair at a time, since the fluorescent tag inhibits 
further polymerization beyond one base pair. 8 -A laser excites the fluorescently-tagged 
dNTPs and an image is taken to determine which base (each of which has a different 
emission wavelength) has been added to a position on the flow cell. The fluorescent tag 
is then cleaved and the cycle repeated until the complete DNA strand is synthesized. 
Images taken from lllumina technical handbook38 . 
1.2 Gene Regulation 
Organisms adapt to dynamic environments through the action of transcription 
factors (TFs), which bind to DNA elements and enhance or decrease the 
expression of specific genes. Through the complex feedback of hundreds or 
even thousands of these TFs healthy cells are able survive and thrive in 
response to changes in external temperature, nutrient availability, and other 
environmental stresses. The collected action and interplay of all genes, gene 
products, and molecules inside of a cell is known as a gene regulatory network. 
Although sequences are available for most if not all the genes of many 
prokaryotic and eukaryotic organisms, far less is known about the interactions of 
their corresponding gene products. 
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Traditionally, the regulation of gene expression has been viewed as a relatively 
straightforward process in prokaryotes. In order for a gene to be transcribed into 
RNA and eventually active protein, RNA polymerase must bind upstream of the 
gene, read the DNA sequence, and transcribe a cohesive RNA strand until it 
reaches a stop codon. RNA polymerases bind to specific DNA sequences known 
as promoters, and this binding can be enhanced or blocked through the action of 
TFs. In bacteria two 6 bp consensus sequences are located 10 and 35 bp 
upstream of the start of a gene. These regions give traction to the RNA 
polymerase, and activating TFs bind directly over or near these regions to recruit 
RNA polymerase and initiate transcription39 . In some cases recruitment of RNA 
polymerase can require the actions of multiple transcription factors binding in 
concert, allowing for higher order control of transcription initiation39 (Figure 1.3). 
(•) Simple promoters 
Class I Class II 
·35 · 10 +I -35 · 10 +1 
(b) Complex promoters 
Class I + Class II Class I • Class I 
·35 -10 +1 ·35 -10 +1 
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Figure 1.3 1 Overview of TF-Mediated Transcriptional Initiation. A depiction of 
the interactions between TFs and RNA polymerase responsible for initiation of gene 
transcription is shown. Two general mechanisms are suggested : Class 1 TFs bind far 
upstream of gene promoters and recruit the RNA polymerase down to the promoter 
region, while Class 2 TFs bind directly over the promoter region and lock in the RNA 
polymerase this way. RNA recruitment can require the action of multiple TFs in some 
instances. Reprinted from Current Opinion in Microbiology, 7(2) , Barnard , A., Wolfe, A. & 
Busby, S., Regulation at complex bacterial promoters: how bacteria use different 
promoter organizations to produce different regulatory outcomes, 103, 2004, with 
permission from Elsevier39 . 
Alternatively, TFs can act to repress transcription of a gene by occluding its 
promoter region to directly prevent binding of the RNA polymerase, competitively 
binding to an activating TF's binding region to prevent TF recruitment of the RNA 
polymerase, or changing the 30 structure of the chromatin to reduce the 
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accessibility of the promoter region40 . TFs can work together to create complex 
network architectures, including feed-forward loops, feedback mechanisms, and 
auto regulatory systems41 . The implications of these complex regulatory 
interactions are only beginning to be understood. A fortunate side effect of the 
rise of NGS platforms is the creation of new experiments capitalizing on high-
throughput technologies to increase our understanding of regulatory networks 
within the cell. One of these methods is ChiP-Seq. 
1.3 ChiP-Seq 
Chromatin immunoprecipitation followed by sequencing (ChiP-Seq) is a 
technique used to determine genome-wide, in vivo interactions between DNA 
regions and transcription factors or other chromatin binding proteins. The 
procedure stems from the basic ChiP protocol, first developed by Solomon and 
Varshavsky in 1988, whereby DNA inside cells is cross-linked to bound proteins 
with formaldehyde, genomic DNA is isolated , fragmented , and 
immunoprecipitated with an antibody specific to the protein of interest, and the 
crosslink is reversed to yield DNA (Figure 1.4) 42 . DNA is then size separated on 
a gel and excised, sequenced, and aligned to a reference genome to identify 
locations where the protein was bound (Figure 1.5). Since ChiP-Seq is 
performed on a population of cells, enrichment of reads over a specific region of 
the genome signifies repeated , unique binding events across separate cells . 
ChiP-Seq has numerous benefits, including high sensitivity and specificity43 .44 
and spatial resolution of binding sites approaching the single nucleotide level45 . 
In comparison to ChiP-chip, which uses microarrays to profile interacting 
genomic DNA regions, ChiP-Seq is more economical44, has a higher signal to 














purify DNA and 
prepare for sequencing 
Figure 1.4 1 ChiP Protocol47. Schematic overview of the ChiP workflow. Reprinted 
with permission from Macmillan Publishers Ltd: Nature Methods, Mardis, E. R. ChiP-
seq: welcome to the new frontier. 4, 613-614 (2007)47 . 
Using an episomal flag-tagged protein expression plasmid with a tetracycline-
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inducible promoter, our lab has generated comprehensive in vivo ChiP-Seq 
binding profiles for more than 50 MTB transcription factors45. These results have 
been used to develop a genome-scale model of MTB transcription factor 
interactions, and have identified new binding sites for several factors known to be 
key mediators of MTB survival and pathogenesis. These results also raise new 
12 
questions, particularly about discrepancies between predicted and observed 
binding sites in vivo, the effects that protein interactions and intracellular 
molecules have on binding affinity, and potential different regulatory roles 
between low affinity and high affinity binding sites. 
A 
• Forward read 

















<> $ ~ ~ ~ ~ § # 
Coordinates (bp) 
Figure 1.5 1 ChiP-Seq Read Profile48 . Overview of the theory behind ChiP-Seq. (A) 
Genomic DNA from a cell population is cross-linked to preserve DNA-TF interactions, 
isolated with the ChiP protocol with an antibody against the TF of interest, and then 
sequenced. (B) Reads are then aligned to a reference genome, and enriched coverage 
over background signifies a consensus of unique binding events in separate cells 
between a TF and that region. Reprinted by permission from Macmillan Publishers Ltd : 
Nature Methods, Valouev, A. et al. Genome-Wide Analysis of Transcription Factor 
Binding Sites Based on ChiP-Seq Data. 5, 829-834 (2008).48 . 
1.4 Sequencing Visualization Tools 
Current NGS platforms generate billions of sequence reads in a matter of days, 
and effective visualization of this data is consequently no small task. In order to 
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· evaluate trends in our sequencing data we employ GenomeView, a free genome 
browser designed specifically to visualize NGS data49. GenomeView supports 
most common sequence file formats, including FAST A, BAM, and GFF, and can 
also compress outdated file formats for more efficient data manipulation. A 
sample representation of GenomeView output is shown below in Figure 1.6. 
Figure 1.6 I GenomeView Interface. ChiP-Seq data for an MTB TF is shown 
mapped against the MTB genome. Green areas represent forward read coverage, blue 
areas represent reverse read coverage, and yellow areas represent total coverage over 
a region on the genome. GenomeView can accommodate many different data tracks, 
including annotation for genes, protein translational products across multiple translation 
frames for a given nucleotide sequence, and multiple alignments for sequencing data. 
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1.5 Problem Overview 
The lifecycle of MTB is marked by dramatic environmental changes between its 
growth state during active TB and a state of dormancy in the hypoxic, nutrient 
deficient interior of the granuloma. MTB's success as a pathogen relies on its 
ability to adapt to a dynamic environment, and transcription factors are the 
effectors that accomplish this goal through the regulation of gene expression. 
The gene regulatory network our lab has constructed from ChiP-Seq data 
provides unprecedented insight into transcription factor binding in vivo; however, 
these binding events are affected by unknown intracellular factors, including 
chromatin orientation, the contributions of protein complexes, and the presence 
of other chemical mediators. Less than half of the predicted binding sites of 
transcription factors are actually bound in our ChiP-Seq studies45 , suggesting 
that either bioinformatics models of protein binding are insufficient or that 
unknown in vivo interactions are major determinants of binding. Even more 
puzzling is the finding that only 24% of ChiP-Seq binding peaks are located in 
intergenic regions upstream of genes45 , suggesting the classical model of 
prokaryotic TF binding and regulation may be incomplete. Through this work, we 
seek to leverage high-throughput sequencing technologies to gain insight into the 
drivers of transcription factor binding across diverse environmental conditions. To 
that end, we have employed low throughput EMSAs and a high-throughput in 
vitro protein binding assay to characterize TF binding affinity to an exhaustive set 
of DNA probes. The results of this work are contained within . 
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2 Protein Binding Studies 
2.1 Motivation 
Our lab has conducted extensive ChiP-Seq studies to generate complete 
genomic binding maps for more than 50 MTB transcription factors, but in vivo 
binding behavior for a given TF is affected by the actions of other TFs, the 
presence of intracellular molecules and cofactors, and the physical conformation 
and accessibility of the genome. In order to better understand the forces driving 
TF binding behavior and to validate the results obtained from ChiP-Seq, we 
implemented a test system to assess protein binding affinity under controlled , in 
vitro conditions. 
2.2 Protein-DNA Binding Assays 
Several methods exist to study protein-DNA interactions in vitro, but the 
electrophoretic mobility shift assay (EMSA) is arguably the most straightforward 
technique for this purpose: First demonstrated in 1981, EMSAs use gel 
electrophoresis to separate unbound protein from protein-DNA complexes based 
on size, charge and shape50·51 . In this method protein is incubated with labeled 
DNA for a brief period in a binding buffer before being run on a gel and 
transferred to a membrane. After visualization , protein-DNA complexes will 
appear as molecularly larger band shifts when compared to unbound DNA. The 
type of DNA labeling used highly influences the assay's sensitivity, and 
radioactive labeling with [32P]phosphate is a common approach52 . A number of 
16 
EMSA derivatives have been adapted from the basic protocol, including 
techniques to study protein-protein interactions53 , attempts to preserve DNA-
protein equilibrium through rapid reaction temperature decreases54, and 
experiments to determine the quaternary structure of protein required to 
successfully form a protein-DNA complex55. Difficulties with protein-DNA complex 
dissociation inside the gel, inherent electrophoretic properties of protein and DNA 
unrelated to the complex, and potential mismatches between the time stability of 
the binding complex as compared to the requirements for the reaction 
preparation hinder the ability of the EMSA to give a precise quantitative estimate 
of binding affinity without additional experiments52 . Even with these limitations, 
the EMSA is still a valuable general tool for qualitative analysis of protein-DNA 
binding for most proteins, and can provide more quantitative results under 
controlled conditions. 
2.3 KstR 
Since much of our interest in MTB is driven by its ability to switch into a dormant 
state to survive in the harsh interior of the granuloma, we focused our study on 
TFs believed to be important to this transition. KstR is a well-studied MTB 
repressor TF that controls a large regulon of genes induced during growth on 
lipids56·57 , and many of these genes are also thought to be necessary for survival 
inside the macrophage56. KstR is part of the TetR regulator family, members of 
which are found in many bacteria and are most well known as being responsible 
for the TetR efflux pump that grants antibiotic resistance against tetracycline58 . 
KstR has also been well characterized, and is known to bind a consensus 
palindromic DNA motif6•57 , making it an ideal initial candidate for our studies. 
2.4 DIG System 
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To perform EMSAs DNA probes must be tagged with a label to allow for 
visualization of the unbound DNA and the protein-DNA complex. To avoid the 
potential hazards of radioactive DNA labeling, we have opted to use a Roche 
Digoxigenin (DIG) chemiluminescent kit. With this system, DNA probes are 
labeled with a DIG-11-ddutp through the action of a terminal transferase. DIG is a 
steroid hapten found only in the leaves of the foxglove plant, and consequently 
the DIG antibody binds solely to correctly labeled DNA, resulting in low 
background signal59 . Terminal transferase indiscriminately extends DNA from the 
3' terminal, while ddutp is a modified nucleoside triphosphate that lacks a 3' 
hydroxyl group and thus terminates chain elongation after its incorporation, 
ensuring the addition of only a single labeled nucleoside. Detection of the label is 
accomplished by addition of an anti-DIG antibody conjugated to alkaline-
phosphatase followed by incubation of the complex in the chemical CSPD. 
Alkaline phosphatase degrades CSPD to the metastable phenolate anion, which 
degrades and produces light that can be captured by X-ray film60 . The reaction is 
highly sensitive with a detection limit on the order of 0.1 pg of labeled DNA 59 . 
To perform the labeling reaction, ssDNA templates are mixed in a 1:1 molar ratio, 
heated to 95°C for 10 minutes, and then slowly cooled to room temperature to 
anneal into dsDNA. 3.85 pmol of dsDNA template is then added to a reaction 
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buffer consisting of CoCb, labeling buffer, DIG-ddutp solution and terminal 
transferase, transferred to 3rc for 15 minutes to perform the reaction, and then 
the reaction is quenched on ice with the addition of EDTA61 . Labeled DNA probes 
are stored at -20°C until needed for an EMSA reaction. 
2.5 EMSA Protocol 
EMSAs were performed with DIG labeled DNA probes and purified KstR 
obtained from collaborators at Los Alamos National Laboratories. KstR stocks 
were aliquoted into a protein storage buffer (1 0 mM Tris, 50 mM NaCI, 10% 
glycerol) and stored at -80°C until needed in single-usage amounts to avoid 
potential degradation from freeze-thaw cycles. KstR purity and size were 
confirmed with a western blot against a His tag (included on the c terminal of the 
protein for purification) to ensure protein quality (Figure 2.3) . EMSA assays were 
performed by first combining labeled DNA, binding buffer (1 OmM Tris, 50mM KCI, 
1 mM OTT final concentration) , and water in a microcentrifuge tube on ice. KstR 
was always added last, and then the solution was mixed gently by tapping, briefly 
centrifuged, and placed in a tube rack at room temperature for 25 minutes to 
facilitate binding. Total reaction volume was maintained at 10 1-11 for all 
experiments. Several polyacrylamide gel types and percentages were used to 
optimize the protocol, and the most consistent results were achieved with 
standard 7.5% TGX gels pre-run in 0.5x TBE buffer for 45 minutes at 80V prior to 
gel loading. 
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2.6 KstR EMSA Validation 
We first sough to establish the reliability of our ChiP-Seq results as an indicator 
of binding affinity in vitro. We selected 2 DNA probes of 41 bp length centered ori 
KstR ChiP-Seq binding peaks corresponding to intergenic regions upstream of 
genes Rv3525c and Rv3574, as well as a single 41 bp probe centered inside the 
gene Rv0124 with no sign of ChiP-Seq enrichment. Interestingly, Rv3574 is the 
gene coding for KstR, suggesting KstR exhibits auto regulation . ChiP-Seq data 










Figure 2.1 1 EMSA Probe Selection Based on ChiP-Seq Data. ChiP-Seq data 
for KstR over intergenic regions upstream of Rv3574 (KstR) , Rv3525c, and a region 
inside the gene Rv0124 from top to bottom. Each lane is paired with control data over 
the same region for comparison. Black circles signify the regions 41 bp DNA probes 
were selected from. 
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An EMSA was carried out to test these regions (Figure 2.2), and the results 
indicate a strong shift for both regions with ChiP-Seq enrichment (Rv3525, 
Rv3574) without any shift for the region lacking ChiP-Seq enrichment (Rv0124). 
Based on these results, Rv3525c was selected as a good positive control 
candidate for future EMSA studies. 
Lane 1 I 2 I 3 4 I 5 I 6 1 I 8 I 9 
DNA Rv3525 Rv3574 Rv0124 
[KstR] 0 I 2 .3~M I 4 .6~M 0 I 2.3~M I 4 .6~M 0 I 2 .3~M I 4 .6~M 
Figure 2.21 KstR Binding Behavior for Rv3574, Rv3525c, and Rv0124. EMSA 
results indicate a strong shift for Rv357 4 and Rv3525c and no shift for Rv0124. 
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We then explored the effects of DNA probe size on protein-DNA complex 
formation. In general, longer probes will produce less of a size shift between 
unbound nucleic acid and a protein-DNA complex, while shorter probes can 
introduce structural and electrostatic interference issues that mask the true 
protein-DNA interaction52 . Since KstR is known to bind a core palindrome of 14 
bp length57 , we assessed probes based on the core motif located within Rv3525c 
with accessory base padding to a length between 21 and 25 bp (Figure 2.4) and 
from 15, 20, 25, 30, and 41 bp (Figure 2.5). Note that accessory bases added to 
the core motif correspond to the sequence of the Rv3525c region. No binding is 
observed between KstR and DNA probes less than 20 bp in length (Figure 2.4), 
while a clear shift is apparent for DNA probes of length 25, 30, and 41 bp (Figure 
2.5). The appearance of additional, larger bands for 30 and 41 bp conditions is 
not a phenomenon replicated in later EMSAs and is possibly a result of protein 
degradation or complex dissociation inside the gel during the run. Lack of binding 
to probes 15 bp or shorter suggests KstR is unable to bind fragments below this 
length, although whether this is due to a lack of affinity or conformational 
changes that render the DNA inaccessible to protein binding in general is 
unknown. Since the original41 bp probe length produced a clear shift, and 
because we were unsure how many accessory bases outside the core motif 
influence KstR binding, we opted to stick with the use of 41 bp DNA probes in 
EMSA studies to provide safety factor beyond the 14 bp known motif. Note that 4 








Figure 2.3 I KstR Purity and Size Confirmation. 9 !Jg of His-tagged KstR was run 
on a 7.5% gel and developed according to standard protocol. The observed size 
correctly aligns with the known size of 22 kDa without any sign of protein degradation. 
Lane 1 I 2 3 I 4 5 I 6 7 I 8 9 I 10 
DNA 21 bp Rv3525 22 bp Rv3525 25 bp Rv3525 24 bp Rv3525 23 bp Rv3525 
[KstR] 0 IJM I 2.31JM 0 IJM I 2.31JM 0 IJM I 2.31JM 01JM 12.31JM 01JM I 2.31JM 
Figure 2.41 KstR Binding Affinity with 21-25bp Probes. EMSA results for KstR 
binding with probes varying between 21 and 25 bp in length. All DNA probes contained 
the consensus binding motif flanked symmetrically by genes in the promoter of Rv3525c 
to fulfill the length specification . 
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Lane 1 2 I 3 4 I 5 6 1 7 8 I 9 
Length 41 bp 30 bp 25 bp 20bp 15 bp Rv3525 
(KstR] 2.3~M 2.3~M I O~M 2 .3~M I O~M 2.3~M I O~M 2 .3~M I O~M 
Figure 2.5 1 KstR Binding Affinity with Varied DNA Probe Lengths. EMSA 
Results for KstR binding to probes ranging in length from 41 bp (left) to 15 bp (right). All 
DNA probes contained the consensus binding motif flanked symmetrically by genes in 
the promoter of Rv3525c to fulfill the length specification . 
We next sought to determine how well ChiP-Seq binding peak height and 
bioinformatics assessment of motif affinity predicted in vitro KstR binding 
preference. Anna Lyubetskaya, a bioinformatics graduate student in our lab, 
applied the MEME software suite to KstR ChiP-Seq data. MEME, which stands 
for Multiple EM for Motif Elicitation, takes a set of DNA sequences as input and 
performs operations similar to a multiple sequence alignment to identify motif 
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patterns in the sequences that are statistically significant as compared to the 
likelihood of random occurrence 52 . The end result of this process is an 
identification of motifs in the DNA sequence data which correspond to the 
predicted KstR binding motif, as well asp-values to indicate how likely that motif 
would have occurred by random where lower p-values equate to higher expected 
binding affinities. We took the -log10 of p-values for motifs generated in this 
manner and then selected candidate regions from ChiP-Seq data spanning a 
range of both motif scores and ChiP-Seq peak heights (Figure 2.6). The amount 
of DNA used in each assay was iteratively optimized, and images included in 
Figure 2.6 were taken from EMSAs with .5 ng of labeled DNA per well, which is 
an 8 fold reduction from the amount used in Figure 2.5. This decrease in DNA 
amount also eliminated the issue with unexplained background at high molecular 
weight in the first lane of Figure 2.5. 
In an attempt to quantify binding affinity, EMSA images for several DNA probes 
were analyzed across triplicate experiments with lmageJ software to quantify 
shift band intensity. Probes were normalized against free nucleic acid band 
intensities in control wells without the addition of KstR. Values for this analysis 
are supplied in 
Table 2.1, and this information is display graphically in Figure 2.7 and Figure 2.8. 
Plots of fluorescence against ChiP-Seq peak height and motif score were 
generated using Python's matplotlib library. Error bars represent one standard 
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error of the mean (S.E.M.) , which was chosen over standard deviation partly for 




Figure 2.6 I KstR EMSAs. Selected EMSA results are displayed to give example 
results for the procedure. 
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Genes ChiP Height Motif Score 
Rv3573 48 5.15 
Rv3525 131 12.15 
Rv0686 72 10.34 
Rv3515 60 12.63 
Rv1628 58 9.77 
Rv3520 33 8.48 
Rv2798 58 8.8 
Rv0218 40 7.9 
Rv3519 37 9.2 
Rv0124 0.2 N/A 
Table 2.1: KstR ChiP-Seq Enrichment and Motif Scores for Gene Promoter 
Regions. Values are provided as a reference for the EMSA results and correlations 
shown in Figure 2.6. Motif score is calculated as the -log1 O(MEME motif p-value) . 
Region Rv3573 Rv3525 Rv0686 Rv3515 Rv1628 Rv3520 Rv2798 
Fluorescence 28.9 82.2 72.7 76.1 55.8 17.9 14.8 
S.E.M. 6.0 20.4 17.6 21.3 26.4 10.9 6.2 
ChiP Height 48.0 130.7 72.0 60.3 58.2 37.4 58.3 
Motif Score 5.2 12.2 10.3 12.6 9.8 8.5 8.8 
Table 2.2 I KstR-TF Binding Intensity. Mean fluorescence intensity of band shifts, 
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Figure 2.71 KstR-DNA Band Shift Intensity vs. ChiP-Seq Peak Height. 41 bp 
DNA probes were designed based on the promoter regions of genes with observed 
ChiP-Seq binding peaks. The fluorescence intensity of EMSA bands shifts was 
calculated using lmageJ software and normalized across experiments to unbound DNA 
band intensity in a control lane without the addition of KstR. Positive correlation is 
observed between EMSA band shift intensity and ChiP peak height (r = .69). Error bars 
represent one standard of error of the mean, which was chosen over standard deviation 
to avoid overlap of two data points with the near identical ChiP-Seq peak heights but 
different EMSA fluorescence values. Significant variation in measurements between 
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Figure 2.8 1 KstR-DNA Band Shift Intensity vs. DNA Probe Motif Score. 41 bp 
DNA probes were designed based on the promoter regions of genes with observed 
ChiP-Seq binding peaks. The fluorescence intensity of EMSA bands shifts was 
calculated using lmageJ software and normalized across experiments to unbound DNA 
band intensity in a control lane without the addition of KstR. DNA probe motif score is 
calculated as -log1 O(MEME p-value) , and better binding motifs have higher scores. 
Results show a significant correlation between EMSA band shift intensity and DNA 
probe KstR binding motif score (r = .78). 
2.7 Sequence Context of KstR Binding Motifs 
KstR is known to bind a 14 bp palindromic consensus motif, consisting of an 8 bp 
core flanked by 2 varied nucleotides on either side sandwiched between a 'T' 
and an "A" base57 . Anna Lyubetskaya, a bioinformatics graduate student in our 
29 
lab, noticed instances in our ChiP-Seq data where an exact KstR binding motif 
appeared multiple times throughout the genome with significantly different ChiP-
Seq enrichment at each occurrence (Figure 2.9) . To determine whether this 
variation was a result of intracellular interactions or sequence based differences 
in binding affinity we selected an 11 bp truncated subsequence of the 14 bp 
consensus motif, which occurred 8 times throughout the MTB genome. We 
chose 4 of these occurrences and designed 41 bp DNA probes centered around 
this 11 bp motif, drawing an additional 15 bp on each side of the motif from the 
surrounding genome context (Figure 2.9). Two EMSA experiments were 
conducted with these probes to assess KstR binding affinity (Figure 2.1 0). 
Results indicate differences in binding affinity in vitro, as the probe with the 
highest ChiP-Seq peak (642823) has a clear gel shift with no visible unbound 
nucleic acid when KstR is added while other regions show high levels of residual 
unbound DNA with a less distinct gel shift. The limitations of the EMSA are 
apparent in the difficulty in distinguishing differences in binding behavior between 
the other three regions tested . 
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Figure 2.9 1 KstR ChiP-Seq Binding Profile for an 11 bp Binding Motif in 
Diverse Sequence Contexts. An 11 bp DNA sequence containing core elements of 
the 14bp KstR consensus binding motif is repeated throughout the MTB genome at 
coordinates 387276, 642823, 2010766, and 41 05855 (black circles indicate location) . 
KstR ChiP-Seq enrichment over these areas is inconsistent, highlighting the importance 
of either accessory bases to this 11 bp sequence or unknown in vivo effects on binding . 
Each lane is shown paired with a background control lane for reference. 
Center Sequence Height 
387276 CCGCGATCGACTCGAAGAACGTGTTGGGCACGATCCGCGAG 1.7 
642823 TCATCTGGCAAGACTAGAACGTGTTGCAATTTGGATCTGCC 131 
2010766 CGGATTCGGCACCAAAGAACGTGTTGGCATCCTTGGCAATT 11 
4105855 TGGCCAACAGCATCAAGAACGTGTTGGGCATCGATGCGGTG 2 
Table 2.3 I Genomic Context Specificity of KstR ChiP-Seq Enrichment. The 
same 11 bp truncated binding motif for KstR was located in 4 separate instances of the 
genome with significant differences in ChiP-Seq peak height. 41 bp probes were 
designed to surround the motif and incorporate accessory bases from its genomic 
context. The center position of the DNA probe is given, along with the entire probe 
sequence with the core motif highlighted in red and the ChiP-Seq peak height. 
31 
Lane 1 I 2 3 I 4 5 I 6 7 I 8 9 I 10 
Region Rv0124 Rv3525 387276 642823 2010766 
KstRl OuM l4.6uM 0 uM l4.6uM o uM l4.6uM 0 uM l4.6uM 0 uM I 4.6uM 
Lane 1 I 2 3 I 4 5 I 6 7 I 8 9 I 10 
Region Rv0124 387276 642823 2010766 4105855 
KstR] 0 IJM 14.6 IJM 0 uM l4.6uM o uM l4.6uM 0 uM l4.6uM o uM I 4.6uM 
Figure 2.10 1 Genomic Context Specificity EMSA. EMSA results for KstR binding 
against 41 bp probes with a conserved core motif and diverse accessory base contexts. 
Region information corresponds either to the genes Rv3525c and Rv0124 as positive 




EMSA analysis of KstR has validated a general correlation between KstR ChiP-
Seq enrichment over a region and KstR binding affinity to that region in vitro 
(Figure 2.7, ~ = .47), a well as a stronger correlation between predicted KstR 
binding affinity from bioinformatics analysis and KstR ChiP-Seq enrichment 
(Figure 2.8, ~ = .6). This difference is not surprising , as bioinformatics 
measurements of binding affinity do not consider intracellular factors that can 
affect binding reflected in ChiP-Seq data. We have also determined the minimum 
length of DNA probes for KstR binding in vitro, and explored the relationship 
between genomic location of binding motifs and KstR binding affinity for an 
isolated case. Our limited experiments with the genomic context of binding 
regions indicate individual base differences outside of a conserved 11 bp core 
motif can have significant effects on binding affinity. Although it would be 
possible to exhaustively test the effects of single base substitutions on TF 
binding affinity to DNA probes with EMSAs, this would be a laborious process 
since each polyacrylamide gel is limited to 1 0 sample conditions and KstR alone 
has over 200 reported binding sites. The costs and labor involved in manually 
designing and testing DNA probes for even a fraction of these sites would be 
prohibitive. EMSA results also displayed extreme variability and significant 
qualitative differences between experiments, including differences in the width of 
the band shift, smears of labeled DNA in the wells, and the appearance of 
multiple distinct shifts in a single well. It is unknown if these qualitative 
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differences are significant for binding affinity or simply artifacts of the gel loading 
process. Experimental error is also easily compounded, as the procedure to set 
up an EMSA requires dozens of pipetting steps intermixed with mixing, waiting , 
and gel loading steps. Small differences in wait times, pipet mixing volumes, and 
loading speed can conceivably have dramatic impacts on the outcome of a study 
meant to preserve the integrity of a poorly characterized protein-DNA complex. 
Although useful for qualitative characterization of TF binding behavior, the EMSA 
is unsuited for the precise, quantitative investigation of TF-DNA binding affinity 
that we wish to pursue. For these reasons we seek to implement HiTS-FLIP, a 
high throughput, quantitative protein-DNA binding assay, in order to fully 
characterize the binding properties of transcription factors important to the 
hypoxic response and lipid catabolism in MTB. 
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3 HiTS-FLIP 
3.1 HiTS-FLIP Overview 
'High-throughput sequencing'-'fluorescent ligand interaction profiling' (HiTS-FLIP) 
is a quantitative protein-DNA binding assay developed by the Burge lab at MIT. 
The idea behind the method is conceptually simple: random DNA is affixed to a 
flow cell and sequenced according to standard lllumina protocols to generate 
-100 million distinct DNA clusters, complementary strands of modified 
nucleotides built during sequencing are stripped away and rebuilt using a Klenow 
polymerase to create regular dsDNA, and fluorescently tagged proteins are 
flowed over the strands, excited, and imaged 53 (Figure 3.1 ). By aligning the 
locations of the fluorescent proteins with the locations of the sequenced DNA 
probes, protein-binding affinity can be calculated for each DNA strand. 
• Flow cell !!!!:! Adaptors 
1111 dsDNA mn Modified 
nucleotides 
-
Transcription Q Fluorescent 
factor tag 
Sequencing Wash; anneal primer; Flow low protein concentration; Flow higher protein concentration; 
... rebuild dsDNA ... image ... image 
Figure 3.1 I HiTS-FLIP Overview63 . From left to right: random ssDNA probes are 
affixed to a flow cell and sequenced according to standard lllumina protocols; 
complementary fluorescently modified nucleotides are denatured, and dsDNA is built 
using a Klenow polymerase; fluorescently tagged transcription factors are applied to the 
flow cell and their fluorescence is imaged; the process is repeated at higher 
concentrations to determine binding affinity. Reprinted by permission from Macmillan 
Publishers Ltd: Nature Biotechnology, Nutiu , R. et al. Direct measurement of DNA 
affinity landscapes on a high-throughput sequencing instrument. 29, 659-664 (2011 )63 . 
35 
Randomized DNA is used to ensure exhaustive, unbiased coverage of potential 
DNA binding motifs, and the technique draws from millions of recorded binding 
events to generate extremely precise measurements of binding affinity. HiTS-
FLIP is consequently an excellent technique to overcome the limits of more low-
throughput EMSA studies, and we adapted the method to generate high-
throughput binding data for the MTB TF KstR against roughly 50 million DNA 
target probes through the use of a fluorescent protein tag. 
3.2 Fluorescent Protein Tags 
Since the discovery in 1962 that a protein was responsible for the unusual 
bioluminescence of the jellyfish Aequorea victoria64 , fluorescent proteins have 
been widely exploited to become ubiquitous and invaluable tools in biological 
research. Green fluorescent protein, or GFP, is the most popularized member of 
this protein class. Structurally, GFP consists of an outside container of beta 
sheets with alpha helices that cap and extend into the interior of the protein in a 
conformation dubbed the "beta can"65 . GFP has the advantageous properties of 
amenability to protein tagging on either of its terminals65 , utilization of a host-
independent, autocatalytic chromophore maturation process driven by oxygen 
and without the requirement for other cofactors66 , and the ability to generate 
spectrally distinct color variants through directed mutagenesis67 . Although GFP 
and its derivatives span a wide range of the color palette, red and orange 
fluorescent proteins have instead been created from OsRed, a protein derived 
from the coral Dicosoma68 . OsRed employs the same initial chromophore 
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maturation process as GFP, but then undergoes an additional oxidation reaction 
to generate a functional red chromophore68 . Wild type OsRed exhibited incredibly 
slow maturation times, and was consequently mutated by several groups to 
create first better performing red chromophores68 and then a set of monomeric 
red, orange, and yellow proteins with emission maxima between 550 and 650 
nm69 . One of these proteins, mOrange, has excitation (548 nm) and emission 
(562) frequencies with similar spectral properties as the lllumina fluorophore tag 
for the nucleotide thymine, and when present on the flow cell mOrange will be 
registered as if it were the thymine base during a standard sequencing run. The 
inherent compatibility of mOrange with lllumina's imaging software makes it an 
ideal tag for the HiTS-FLIP protocol, as no modifications to the laser or 
calibrations of the imaging software will be required. 
3.3 Cloning Optimization 
In order to perform HiTS-FLIP a fusion protein containing both mOrange and 
KstR with the full functionality of both components was designed, optimized, and 
expressed. To accomplish this, a pET151/D-TOPO vector containing mOrange, 
an ampicillin resistance marker, and a T? promoter for expression was obtained 
from collaborators at the Burge lab at MIT. D-TOPO series vectors rely on the 
enzyme topoisomerase I, which binds and cleaves a single strand of dsDNA after 
a 5 bp sequence (CCCTT), leaving a 4 bp overhang70 . Topoisomerase I can 
subsequently religate the cleaved DNA strand to make dsDNA, but can also 
incorporate another DNA fragment with a complementary overhang to the intact 
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single DNA strand71 . Invitrogen has designed their D-TOPO series vectors to 
exploit this phenomenon for fast and efficient cloning of dsDNA inserts, obviating 
the need for enzymatic digestion and subsequent ligation to incorporate DNA 
inserts into plasmids72 . Although D-TOPO cloning is appealing for creating a 
single functional expression construct, the resulting vector lacks unique enzyme 
cut sites at the gene insertion site. For this reason it was infeasible to insert KstR 
directly upstream of mOrange, and the lack of a pair of unique cut sites in the 
vector downstream of mOrange also rendered insertion of KstR after mOrange 
impossible (Figure 3.2). It was thus decided to PCR amplify the mOrange gene 
and insert it into another vector. Appropriate primers were designed to PCR 
amplify mOrange using the PET 151 D-TOPO construct as a template. KstR was 
also amplified from genomic MTB DNA, and both genes were inserted together 
into the PT?-Fiag-4 expression vector (Sigma Aldrich) with an 18bp linker 
separating the two through standard enzymatic digestion. A polyhistidine tag 
followed by a stop codon was also placed at the end of the fusion construct to 
ensure expression of only KstR-mOrange-His without the additional FLAG tag 
(Figure 3.3). The KstR-mOrange-His construct and the original PET-151 D-
TOPO construct were both transformed into a BL21 expression strain of E. coli, 
transferred into liquid culture, and incubated for 4 hours with either 0 or 1 mM 
IPTG. 200 IJI of induced and control cultures for each vector were pipetted onto a 
96 well plate and fluorescence was measured (Table 3.1) . Negligible 
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fluorescence increase in the KstR- mOrange fusion after 4 hours as compared to 












Figure 3.21 PET 151 D-TOPO mOrange Vector Map. Of all unique enzyme sites 
downstream of mOrange, only BamHI does not cut KstR. Upstream enzyme sites are far 
removed from the start of mOrange and insertion here would unnecessarily lengthen the 
size of the fusion construct. Image created with SnapGene software. 
500 1000 
01 
T7 promot er 1 
lac operator 
1500 
mOrange t 0 
1 FlAG 
6xHis 
Figure 3.3 1 KstR-mOrange-His construct in PT7-Fiag-4 Vector. KstR and 
mOrange were inserted into the PT?-Fiag-4 vector downstream of the T7 promoter with 
an 18 bp linker between the genes. A 6xHis tag followed by a stop codon was inserted at 
the C-terminal of mOrange prior to the FLAG tag. DNA framing was confirmed via 
sequencing . Image created with SnapGene software. 
Control Induced 
mOrange 3 20 
KstR-mOr 3 4 
Table 3.1 1 PT7 Fusion Construct Fluorescence Measurements. Protein 
fluorescence was measured after induction to determine if mOrange functionality 
in the fusion construct is preserved. Based on these values mOrange does not 
seem to fluoresce as part of a fusion with KstR in the PT7 -Fiag-4 vector. 
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compared to mOrange alone indicates a lack of required mOrange functionality in 
the fusion construct. To test whether the fusion of KstR to mOrange was 
responsible for decreased fluorescence, mOrange was inserted into PT7 -Fiag-4 
without KstR, transformed into the BL21 E. coli expression strain and induced 
with a titration of IPTG concentrations at 3rC. Cultures of cells containing the 
PET 151 0-TOPO plasmid with mOrange alone were also induced with 0 and 1 
mM IPTG for comparison. Fluorescence was measured after 18 hours and the 
cultures were spun down, resuspended in PBS and mechanically disrupted with 
a magnalyzer to harvest protein. A western blot was performed to assay protein 
size and quantity (Figure 3.4). Western results confirm expression of the 
mOrange protein in all conditions, but no fluorescence is observed for mOrange 
expressed in PT7 vector (Table 3.2). 
PET151 0-TOPO PT7 Flag 4 
[IPTG] (mM) 0 1 0 0.1 0.5 1 
Fluorescenc 
e 2 20 2 2 3 2 
Table 3.2 Fluorescence of mOrange in Different Expression Vectors. Culture 
fluorescence was measured after 18 hours of induction. A lack of fluorescent signal in 
the PT? Flag 4 vector as compared to the PET151 D-TOPO vector indicates mOrange is 
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PT7 PT7 PET 151 PET 151 
Figure 3.41 Western Blot of mOrange in PT7 and PET 151 D-TOPO Vectors. 
Western results against the His tagged mOrange expressed in two different vectors. 
Strong bands are apparent at the expected size of mOrange (-30 kDa) for all induction 
conditions. Larger bands in the PET 151 0-TOPO induction may be indicative of protein 
aggregation, while smaller bands in all conditions are likely degradation products. 
A final attempt to use a different vector was made by cloning mOrange into PET 
101 0-Topo, another vector in the same series made by Invitrogen. PET 101 0-
TOPO differs from PET 151 0-TOPO by having a 6x His tag moved downstream 
of the insertion site, and consequently the T7 promoter site is directly upstream 
of where the gene is inserted with no other tags in between. As before, mOrange 
was PCR amplified with appropriate primers, inserted into PET 101 0-TOPO 
using the 0-TOPO overhang incorporation cloning strategy, transformed into 
TOP 10 E. coli and harvested for plasmid which was confirmed by sequencing. 
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Confirmed PET 101 D-TOPO with mOrange was then transformed into BL21 E. 
coli, transferred into liquid culture, split, and treated with either 0 mM or 1 mM 
IPTG. Cultures of cells containing the PET 151 D-TOPO plasmid with mOrange 
alone were also induced with 0 and 1 mM IPTG for comparison. After 4 hours of 
induction at 37 oc fluorescence measurements of the cultures were taken in a 
plate reader (Table 3.3) before cells were pelleted and magnalyzed to harvest 
protein for a western blot (Figure 3.5) . To our frustration, mOrange did not 
fluoresce in the PET 101 D-TOPO vector. Following these experiments, we spent 
more time testing the effects of polyhistidine tag placement on each terminal of 
mOrange in both the PET 101 D-TOPO and PT7-FLAG-4 constructs as well as 
removing the polyhistidine tag altogether. Despite our best efforts, no successful 
strategy could be devised to preserve mOrange fluorescence outside of the PET 
151 D-TOPO vector, and the reason for this failure is still unknown. This issue 
was finally solved by cutting out the entire sequence between the Ndel and 
BamHI enzyme sites on the original PET 151 D-TOPO vector (Figure 3.2) , 
ligating in a DNA sequence with new enzyme recognition sites, and then 
inserting mOrange into the construct. This construct was checked for 
fluorescence with a 4 hour induction in BL21 E. coli at 3rc with 1 mM IPTG, and 
results showed a clear increase in fluorescence comparable to the original 
mOrange PET-151 D TOPO vector, resolving the issue. 
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PET101 mOrange PET 151 mOrange 
[IPTG] (mM) 0 1 0 1 
Fluorescence 24 23.3 45 93 
Table 3.3 1 Comparison of Fluorescence of mOrange Expressed in PET 101 
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PET 151 PET 101 PET 101 
Figure 3.5 1 Western Blot of mOrange Expressed in PET 101 and PET 151 D-
TOPO Vectors. Western blot against the polyhistidine tag on mOrange expressed in 
either PET 151 or PET 101 D-TOPO. Both vectors show strong signal at the expected 
size of 30 kDa, while PET 101 D-TOPO also has evidence of a smaller band at 
approximately 25 kDa that is a potential degradation product. 
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Since the placement of both the polyhistidine and fluorescent tag in the fusion 
construct can affect fusion protein function73·74 , we tested constructs with both 
KstR-mOrange and mOrange-KstR orientation. Placement of KstR on theN-
terminal of mOrange resulted in a fusion protein without fluorescence, but luckily 
the construct with mOrange on the N-terminal of KstR produced protein with 
strong fluorescent signal. We then designed plasmids with orientation of 6xHis-
m0range-Kstr and m0range-KstR-6xHis, cloned and confirmed the plasmids 
with sequencing, and induced plasm ids in BL21 E. coli for 4 hours at 3rC with 1 
mM IPTG. Fluorescence measurements were taken and protein harvested as 
before to be used in a western blot (Figure 3.6). Western blot results show 
expression of the mOrange-KstR at the expected size of 50 kDa, with additional 
bands of both higher and lower molecular weight for the C-terminal His construct 
and lower molecular weight bands for the N-terminal His. We suspect that higher 
molecular weight bands represent potential aggregation products, while lower 
weight bands correspond to degradation products. The difference in size in 
degradation products between the N-terminal and C-terminal His tag strategies is 
not surprising given that each strategy would pull down a different half of a 
degraded protein, assuming consistent enzymatic degradation points in both 
proteins. We note that the N-terminal His tag will pull down protein beginning with 
the mOrange half of the fusion, while the C-terminal His tag will pull down protein 
from the KstR side of the fusion . Fragments from the C-terminal purification 
strategy could therefore have fragments of fully functional KstR without functional 
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mOrange, which could complicate measures of binding in the HiTS-FLIP assay. 
Since we do not anticipate binding competition between KstR and mOrange, we 
opted to use the N-terminal His strategy to ensure any KstR with functional 




KstR mOr Species C-terminal His N-terminal His 
Figure 3.6 1 Western Blot of Fluorescent mOrange- KstR with Variable His 
Terminal Placement. Western blot against the polyhistidine tag in the mOrange-KstR 
fusion protein. 
3.4 Finalized Expression Construct 
Protein from the N-terminal polyhistidine terminal tagging strategy was purified 
with a Novagen His Bind Resin kit according to manufacturer protocols and used 
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for an EMSA to test binding affinity in comparison to regular KstR (Figure 3.7). 
Results of the EMSA indicate the mOrange-KstR fusion construct with an N-
terminal His tag has specificity for a known KstR DNA binding region . The lack of 
data for most of the conditions testing untagged KstR is either a result of the high 
molar amount of protein used that may have interfered with migration of the 
sample into the gel, or an imaging artifact introduced during development of the 
film. Although the presence of degradation bands in the purified protein extract is 
not ideal, variations in induction conditions could not eliminate this issue. 
Overnight inductions at room temperature with a titration of IPTG concentrations, 
varied induction times at 3rC, and even the use of chemical cell lysis buffers in 
place of physical disruption with the magnalyzer showed no effect on the 
appearance of degradation bands. All protein samples were immediately 
resuspended in a buffer containing protease inhibitors after lysis, but the 
ineffectiveness of this precaution suggests protein was cleaved inside the cell 
during the induction period. Based on the successful shift of the mOrange-KstR 
protein against a known KstR binding region and the preserved fluorescent 
function of mOrange this configuration it was decided that protein purified from 
this construct would be suitable for pilot HiTS-FLIP studies. A vector map of the 
final construct is show in Figure 3.8. 
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Region 3525c 0124 3525c 0124 
Proteinl (uM) 0 I 1 I 2.5 I 5 5 o I 2 I 5 I 10 10 
Protein Type His-mOrange-KstR KstR-His 
Figure 3.7 I mOrange-KstR EMSA. Purified His-mOrange-KstR was used in an 
EMSA to test binding against a positive control DNA region (3525c) and a negative 
control DNA region (0124). Strong band shifts for mOrange-KstR against the positive 
control and a lack of a shift against the negative control shows that the mOrange-KstR 
protein preserves similar binding preferences to KstR alone. 
Pet 151 KstR morN Terminal HIS 
70 79 bp 
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Figure 3.8 I KstR-mOrange-His Construct map. The KstR mOrange fusion 
construct maintains integrity of both fluorescence activity and binding behavior when 
expressed from the PET 151 construct. This construct contains an ampicillin resistance 
marker for selection and a polyhistidine tag for protein purification . 
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3.5 HiTS-FLIP Protocol 
The HiTS-FLIP protocol is a modification of the standard lllumina sequencing 
workflow for a GAl IX sequencer (Figure 3.1). In the original HiTS-FLIP method 
random oligonucleotides of 25 bp length were sequenced by synthesis, 
denatured, and rebuilt into dsDNA using a Klenow polymerase to test the binding 
affinity of Gcn4p, a yeast transcription factor known to bind a core motif 7 bp in 
length with high specificit/5. In contrast, KstR binds a consensus motif of roughly 
15 bp in length 57. Since the amount of coverage for a specific DNA subsequence 
of length k within a larger DNA sequence of length n decreases by a factor of 4 
each time we increment k, the strategy of using 25 bp random oligonucleotides is 
unlikely to generate a large set of DNA sequences that contain the core motif or 
similar sequences to the core motif. Although there are different potential 
approaches to solve this problem, including biasing the nucleotide composition of 
the probes toward the composition percentages found in the MTB genome or 
manually selecting an exhaustive set of variations on the core motif, we chose 
the simple solution of using successful KstR ChiP-Seq libraries. These libraries 
naturally include all known binding sites for KstR in vivo, and also have roughly 
1 00-fold coverage of the entire MTB genome. We therefore expect a high 
number of likely KstR binding targets to be present in the sample. A KstR library 
prep from an earlier sequencing run was tested with a bioanalyzer to ensure 
quality, affixed to one of the eight lanes of a flow cell using an lllumina cluster 
station, and sequenced on the GAIIx according to standard lllumina protocols. 
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The remaining 7 lanes consisted of E. coli ChiP-Seq library preps and a PhiX 
control lane supplied by lllumina for quality control purposes. The optional step of 
saving images was enabled to allow for analysis in the HiTS-FLIP pipeline. 
After DNA sequencing was completed, the flow cell was kept in place within the 
sequencer and a new recipe script was loaded to perform DNA denatur~tion and 
renaturation with a Klenow polymerase followed by 6 cycles of protein binding. 
mOrange-KstR was added to the flow cell at concentrations of 1 nM, 5 nM, 25 
nM, 125 nM, 625 nM, and 3.125 1-JM in increasing order. Protein was allowed to 
bind for 20 minutes at 20°C degrees prior to imaging. A wash cycle before 
addition of higher protein concentrations was conducted after each cycle, and 
additional images were taken of the flow cell immediately before and after the 
wash to calculate photobleaching corrections and to determine if any residual 
protein was left on the flow cell after the wash. As with the sequencing run , the 
option of saving flow cell images was selected. 
3.6 lllumina RTA software 
Each sequencing run is programmed into the machine control software in the 
form of a recipe file, which contains specific instructions as to when to add 
reagents, change temperature, take images, and perform all other necessary 
steps during sequencing. lllumina sequencers identify bases in a DNA sequence 
on the flow cell by dividing each of the 8 lanes of a flow cell into 120 distinct 
grids, exciting these grids with a laser, and then sequentially imaging these grids 
with a high resolution camera. lllumina provides a Real Time Analysis (RTA) 
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software package to analyze these images. To accurately track and associate 
fluorescence with the correct cluster of homogenous DNA strands on the flow cell 
during sequencing, RTA uses weighted intensity averages over the first four 
bases of sequencing cycles to establish fixed DNA locations for the entire 
sequencing run (see Figure 1.2 for more information on lllumina sequencing and 
cluster generation). This allows the software to distinguish the boundaries 
between different clusters of DNA, and hence determine the sequences for each 
DNA template seeded onto the flow cell without fluorescent interference from 
adjacent DNA strands. The image files generated during the sequencing process 
are on the order of 1 TB for a standard 36 bp single read sequencing run with 
400-500 million clusters of DNA on a flow cell. To efficiently utilize hard disk 
space RTA processes images during the sequencing run to convert them into 
proprietary CIF files , which contain intensity values for every registered cluster 
for each sequencing cycle. Image files are deleted by default during this process, 
and the resulting CIF files reduce disk space utilization by 80-90%. For our 
experiments we saved image files to allow for RTA reanalysis. RTA software also 
performs base calling, and generates a BCL file for each grid in each lane of the 
flow cell for every cycle. The final output from RTA is thus a set of 120 BCL and 
CIF files for each sequencing cycle for each of 8 lanes on the flow cell. 
Information is kept consistent for the same grid for every sequencing cycle, 
meaning that the first entry in a BCL for a given grid will correspond to the same 
DNA cluster in the first entry of the CIF file for that grid. 
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3.7 RTA Cluster Registration 
HiTS-FLIP is possible through comparison of CIF files between a DNA 
sequencing run and subsequent protein binding runs. After RTA standardizes 
cluster position in the first 4 cycles of the sequencing run the image analysis 
software will only search for intensity readings at those locations for the 
remainder of the sequencing cycles. Fluorescence intensity values from the 
protein binding cycles can thus be extracted from CIF files for that cycle and 
cross referenced against the BCL files to associate protein fluorescence with a 
DNA sequence at that position. An unforeseen consequence of separating DNA 
sequencing and protein binding cycles into two separate recipe files was the 
generation of two distinct sets of RTA results. Inconsistencies in cluster 
registration between the DNA sequencing run and protein sequencing run made 
alignment of protein binding data with sequencing data impossible, as any 
inconsistency between the ordering of the data between the two runs would 
throw all cross references out of alignment. The reason for this inconsistency in 
cluster registration is due to the lower level of fluorescence of mOrange as 
compared to the modified dNTPs used in sequencing, as well as the fact that not 
every DNA sequence on the flow cell can be expected to bind with the KstR 
mOrange construct. If even one DNA sequence registered during the sequencing 
run is not registered again during protein binding this problem will arise. 
To solve this problem, the saved image files for the protein binding run were 
reorganized and grouped together with the image files for the DNA sequencing 
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run, and RTA was called using command line arguments to reprocess the files as 
a contiguous set. This generated a consistent set of clusters across both the 
DNA sequencing and protein binding cycles. It is important to note that this 
process is not straightforward, as RTA is not designed to process image files 
after a sequencing run is completed. Several software errors arose during this 
process, and RTA had to be manually restarted several time to gather binding 
data for all 8 lanes of the flow cell. Even with the same set of image files as 
inputs and the same command line arguments RTA would fail to process all 
lanes on the flow cell at once, and would bizarrely have difficulties processing 
different lanes with each separate restart of the RTA software. Consequently, for 
future HiTS-FLIP runs it is highly recommended to structure recipe files to 
perform the DNA sequencing and protein binding cycles together. 
3.8 Intensity Extraction and Processing 
CIF files are a proprietary file format created by lllumina specifically to store 
intensity values extracted from sequencing images. They consist of a header 
section of 12 bytes of information which declare the cycle number, cluster count, 
intensity precision and other identifiers76 . Following this header information, 
intensity values for A, G, C, and T nucleotides are stored in order for each 
cluster76. Scripts written in Python and Perl by Robin Friedman, a collaborator 
involved in the original HiTS-FLIP paper, were adapted to extract intensity values 
from CIF files and pair these values with the corresponding DNA sequences from 
BCL files. DNA sequences were filtered to eliminate any reads without non-zero 
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intensities for the protein binding cycles, which reduced the data set by 40% to 
about 30 million DNA reads. In contrast to the standard HiTS-FLIP method, 
where the complete sequencing of the DNA probe is achieved due to the short, 
25 bp probe length, our binding probes are generated from ChiP-Seq libraries 
with an average length of around 150 bp. This means that a 36 bp sequencing 
run only explicitly identifies a fraction of the true potential binding sequence. To 
account for this, DNA probes were aligned to the MTB reference genome with 
Bowtie2 alignment software. DNA alignment is not a perfect procedure, as 
repetitive DNA sequences, misidentified bases during sequencing, and poor 
quality sequencing makes correct alignment impossible for some reads. Luckily, 
after filtering of reads that registered no intensity values for protein binding runs 
our remaining data aligned at a rate near 80%, resulting in roughly 25 million 
data points for KstR binding. 
3.9 HiTS-FLIP Data Analysis 
Due to information density in analysis images, all figures referenced in this 
section have been grouped together in section 3.1 0. With such a large data set of 
binding measurements, we began by searching for trends indicative of a 
successful experiment. One expectation is that fluorescent signal should 
increase as protein concentration increases for true KstR binding sites, and we 
plotted boxplots of fluorescence for all reads for each protein concentration cycle 
to evaluate this prediction (Figure 3.9). Contrary to our expectations, there is little 
evidence of median fluorescence difference as protein concentration increases, 
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with the exception of a slight increase in fluorescence for the highest protein 
concentration tested, 3.125 IJM. This result indicates an issue with the 
implementation of the experiment or large background signal obfuscating trends 
in true binding sites, and either scenario poses a troubling challenge to accurate 
data interpretation. To help identify the likely reasons of these unexpected 
results, we used the information from our EMSA validations of ChiP-Seq binding 
which supports a positive correlation between ChiP-Seq binding affinity and in 
vitro binding affinity. We reasoned that binding sites with high ChiP-Seq 
enrichment should as a whole display more evidence of KstR binding in HiTS-
FLIP as compared to sites without ChiP-Seq enrichment. We filtered our data to 
consider only reads that aligned to within 20 bp of a ChiP-Seq binding peak for 
KstR and then plotted all these reads together in a boxplot for each binding peak, 
ranking sites by ChiP-Seq peak height. Since our results suggest there may have 
been an issue with the first 5 protein cycles, we only considered data from the 
highest protein concentration (Figure 3.1 0) . We also examined fluorescence 
plotted against the motif score of the binding peak for comparison (Figure 3.11 ). 
A clear trend is apparent in that regions that show high enrichment from ChiP-
Seq also show increased fluorescent intensity. We then compared this data 
across the 3 highest KstR protein concentrations tested (Figure 3.12). A similar 
trend to that displayed in our ChiP-Seq binding data across multiple induction 
conditions (Figure 3.13) emerged, whereby at low protein concentrations only 
high affinity binding sites are bound by TF and enriched in ChiP-Seq. To ensure 
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that this finding is not an artifact driven by the level of coverage for regions over 
the genome (i.e. higher fluorescence is due to nonspecific binding of fluorescent 
protein to more probes over an enriched KstR binding site and not due to higher 
binding affinity), we also extracted KstR ChiP-Seq coverage data over the MTB 
genome to compare fluorescence intensity against coverage. We expect some 
natural correlation between genomic coverage and fluorescence intensity since 
high cover is indicative of KstR binding affinity in ChiP-Seq. To control for this, 
we also identified instances of unbound DNA regions in ChiP-Seq with predicted 
binding motifs for KstR (Figure 3.14 and Figure 3.15). Encouragingly, many 
regions with low ChiP-Seq coverage with predicted KstR binding motifs show 
fluorescent intensity greater than that in many bound KstR sites. Interestingly, 
although regions with very high motif scores show greater median fluorescence 
than average, for most regions motif score does not show a clear trend with 
fluorescent intensity. 
To perform this data analysis, Python scripts were written to group intensity 
values across all protein binding cycles for each DNA sequence which 
successfully aligned to the MTB genome with the genomic coordinate of the 
successful alignment into one master data file. An additional python script was 
then written to reference this data file and quickly extract HiTS-FLIP intensities 
over a specified genomic region corresponding to a window of 20 bp around 
KstR ChiP-Seq binding peaks. Since the average length of DNA in the KstR 
ChiP-Seq library is around 150 bp, any read that aligned with correct strand 
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orientation to a window of 150 bp from the center of the coordinate for the region 
tested was considered when selecting data points for that region. Results were 
plotted using the Python Matplotlib module. 
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Figure 3.9 1 HiTS-FLIP Fluorescent Signal Across Protein Concentrations. 
Boxplots for fluorescence intensity values registered by the sequencer during protein 
binding cycles of HiTS-FLIPs. Since protein concentration increases with cycle number, 
our expectation is that a successful run would exhibit increased fluorescence as cycles 
progressed. The lack of this trend indicates potential issues with the outcome of this 
experiment. Solid blue lines above the boxplots are individually plotted outliers, but due 








KstR Bindi119 sites (Red: Genic II Blue: mtervenic) 
Figure 3.10 1 HiTS-FLIP Fluorescence Localized to KstR ChiP-Seq Peaks. 
HiTS-FLIP fluorescence intensities mapped to reads within a 20 bp window of the top 75 
KstR ChiP-Seq binding peaks are shown. Regions are color coded by location relative to 
gene coding regions, and ChiP-Seq peak height is overlaid in yellow. A clear trend 
between ChiP-Seq peak height and median fluorescent intensity is apparent. 
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KstR Binding Sites 
Figure 3.11 1 HiTS-FLIP Fluorescence vs. Motif Score for KstR ChiP-Seq 
Regions. HiTS-FLIP fluorescence intensities mapped to reads within a 20 bp window of 
the top 75 KstR ChiP-Seq binding peaks are shown with bioinformatics motif score for 
that region overlaid in yellow. Although regions with the highest motif score show larger 
median fluorescence than average, several notable outliers with high HiTS-FLIP median 
fluorescence and low relative motif score are apparent. 
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Figure 3.121 HiTS-FLIP Fluorescence vs. KstR Concentration. HiTS-FLIP 
fluorescence for the top 75 KstR ChiP-Seq binding peaks is shown across increasing 
concentrations of applied KstR (125nm, 625nm, 3.125 1-1M from bottom to top) with ChiP-
Seq peak height overlaid in yellow. Regions with high ChiP-Seq enrichment show a 
gradual increasing trend in median HiTS-FLIP fluorescence in a similar fashion to 
observations from ChiP-Seq data with titrated inducer concentrations (Figure 3.13). 
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Figure 3.131 ChiP-Seq Binding vs. Inducer Concentration45• When induction 
concentrations and resulting intracellular TF concentrations are increased there is a 
clear trend of increased TF enrichment across all binding sites. At low concentrations of 
inducer (and hence TF) only the strongest binding sites for that TF are bound. Image 
reprinted with permission45 . 
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KstR Binding Sites (Red: Bound Sites If Green: Unbound Sites) 
Figure 3.14 1 HiTS-FLIP Intensity vs. Background Coverage. HiTS-FLIP 
intensity values are plotted for KstR binding site regions with background coverage 
overlaid . Regions are divided between confirmed ChiP-Seq binding sites (red) and 
regions without evidence of ChiP-Seq binding that contain binding motifs for KstR 
(green). Although most regions with high HiTS-FLIP fluorescence also display high 
coverage, there is little evidence linking fluorescent intensity and coverage for medium to 
low intensity peaks in confirmed ChiP-Seq regions, and no apparent correlation for 



















KstR Binding Sites (Red: Bound Site II Green: Unbound Site) 
Figure 3.15 1 HiTS-FLIP Intensity vs. Background Coverage and Motif Score. 
HiTS-FLIP intensity values are plotted for KstR binding site regions with background 
coverage and bioinformatics motif score overlaid . Regions with the highest motif score 
tend to have high median fluorescence, but weaker motif scores appear poorly 
correlated with fluorescence intensity. 
63 
3.11 Discussion 
Although there is little evidence for KstR-mOrange HiTS-FLIP binding for 5 of the 
6 protein concentrations we tested, our highest applied protein concentration of 
3.125 IJM does show evidence of specific binding to known KstR binding sites. 
Binding does not seem to be driven simply by the increased number of available 
binding probes over ChiP-Seq enriched regions, as evidenced by the above 
average median fluorescence of many regions with low ChiP-Seq coverage 
containing predicted KstR binding motifs, as well as the finding that this binding 
behavior closely mimics observations from titrated induction of TFs during ChiP-
Seq where only high affinity binding sites show evidence of binding at low TF 
concentrations. We consequently believe that we probed the binding properties 
of KstR using molar concentrations of active protein far lower than what would be 
required to produce even fractional saturation of KstR binding targets. At first 
glance this finding is incongruous with results of in vitro EMSA studies, as molar 
concentrations of KstR at 2.3 IJM produce consistently strong band shifts for a 
number of KstR binding probes with variable intensity between DNA probes 
consistent with expected differences in binding affinity. To further investigate the 
quality of our fusion protein, we repeated an EMSA against known positive and 
negative binding controls for KstR with the mOrange-KstR construct and 
achieved clear results using a different percentage gel (12% vs. 7.5% previously) 
(Figure 3.16). This EMSA shows a stark difference in binding affinity between 
KstR and mOrange-KstR, with significant amounts of unbound nucleic acid 
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visible in the mOrange-KstR condition at twice the molar amount of KstR 
necessary to produce a complete shift of all visible DNA. There is little visible 
change in this residual unshifted DNA band for mOrange-KstR between 4.6 IJM 
and 9.2 IJM protein, suggesting that doubling the molar concentration of purified 
protein increases the amount of functional mOrange-KstR by only a marginal 
amount. These results corroborate our findings and suggest that the amount of 
protein we believed to be present on the flow cell during HiTS-FLIP for each 
protein cycle was grossly overestimated. 
Figure 3.161 mOrange-KstR Optimized EMSA. A clear EMSA result using a 12% 
polyacrylamide gel reveals decreased binding affinity for mOrange-KstR as compared to 
untagged KstR in the form of weaker band shifts and significant remainders of unbound 
DNA at the bottom of mOrange-KstR lanes. 
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Another technical issue was the process of cluster registration, which was 
explored during discussions with Ilium ina staff after completion of the experiment. 
We noticed that DNA sequencing runs display fluorescence intensities about an 
order of a magnitude higher than those during HiTS-FLIP runs, and that the 
image capture system in the sequencer may find it difficult to register the 
fluorescence from low concentrations of fluorescent protein. This problem may 
be somewhat ameliorated by improving the quality of protein used in HiTS-FLIP 
for high protein concentrations, but is still an obvious issue for assessing binding 
affinity at low protein concentrations where we expect minimal binding . 
3.12 Protocol Optimization 
An unfortunate drawback to HiTS-FLIP is price, as the reagents necessary to 
perform a sequencing run cost in excess of $5,000. This makes HiTS-FLIP a 
difficult process to troubleshoot, as any missteps result in a significant loss of 
investment. Luckily, we have arranged a collaboration between lllumina and the 
Burge lab at MIT to perform another HiTS-FLIP run with improved protein quality 
and protocols based on lessons learned from our pilot study. To address our 
issues with functional protein purification, we revisited the induction conditions for 
expression of our protein and carried out short inductions between 1 and 5 hours 
at room temperature. These results identified a 2 hour induction with 1 mM IPTG 
at 18°C as an optimal condition to produce protein without degradation, which is 
a vast improvement over previous induction results (Figure 3.17). 
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Figure 3.17 I mOrange-KstR Varied Induction Conditions. Western results for 
varied induction conditions to express mOrange-KstR. Results show induction at 2 hours 
with 1 mM IPTG at room temperature produce a single band of the correct size of the 
fusion construct (50 kDa) with negligible signs of degradation. 
During our handling of mOrange and mOrange-KstR, we noticed a trend of 
gradual fluorescence increase over time when samples were stored at room 
temperature or 4°C (Figure 3.18). Since fluorescent proteins mature autocatalytic 
ally in the presence of oxygen this is not a surprisingly result, but an unfortunate 
side effect of protein expression at 18°C for only 2 hours is a lack of significant 
fluorescence for the fusion construct, which can only be detected by 
measurements in a plate reader, in comparison to previous inductions at 3rC, 
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Figure 3.181 mOrange Fluorescence Readings Over Time. Fluorescent 
readings for a .1 mg/ml solution of mOrange (red) and a .8 mg/ml solution of mOrange-
KstR (blue) over time. 
Since the registration of fluorescent proteins is not a task lllumina sequencers 
were designed for, it is unclear what the minimum fluorescence requirements are 
for registration by the sequencer. We noted that after 3 days protein fluorescence 
increased by a factor of 10 from its levels immediately following purification. We 
tested the functionality of KstR-mOrange after 3 days with an EMSA (Figure 
3.19) and assessed quality with a western blot (Figure 3.20). EMSA results show 
significant improvement in both the protein-DNA band shift and decreased 
residual unbound DNA, although the western shows some expected degradation 
of the protein even with the addition of protease inhibitors. We are currently in the 
process of optimizing KstR functionality and fluorescence to create an 
appropriate fusion protein for an additional experiment. 
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Figure 3.191 Binding Comparison Between KstR and mOrange-KstR Using 
Improved Expression Conditions. Results indicate a DNA shift for mOrange-KstR 







Figure 3.20 1 Western Blot of mOrange-KstR Using Improved Expression 
Conditions. Western blot results for fresh KstR (left) and purified mOrange-KstR after 
3 days of culture. Some degradation of the mOrange-KstR protein is apparent. 
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To aid in image registration, we have also learned from collaborators at the 
Burge lab that fluorescent labeling of DNA primers used in dsDNA resynthesis 
after the end of the regular DNA sequencing improves the ability of the image 
capture system to detect low level protein fluorescence. Consequently, we will be 
labeling our DNA primers with an Alexa 647 kit, which confers excitation and 
emission spectra that are detected by the sequencer as an adenine base. 
Fluorescent labeling of the DNA in a noncompetitive channel to mOrange 
fluorescence ensures the laser will be able to register clusters in the absence of 
protein binding , and fluorescently labeled DNA will thus serve as a stable 
guidepost for the laser and camera capture system to accurately record clusters 
across all protein binding intensities. 
With these changes we hope to significantly improve upon our HiTS-FLIP results 
to probe KstR binding affinity across a wide range of protein concentrations. This 
information will provide valuable insight into the MTB regulatory network and the 
role that KstR plays in disease pathogenesis, and successful implementation of 
the HiTS-FLIP protocol will lay the groundwork for expanded study of other MTB 
TFs. With an accurate understanding of TF binding affinity both in vitro and in 
vivo, differences in the system response of a TF across environmental conditions 
can be accurately modeled, allowing for systemic identification of the functional 
determinants of TF binding77 . It is our hope that this work and its continuation will 
elucidate the workings of the MTB regulatory network and allow for the creation 
of better treatments to ease the global burden of tuberculosis. 
4 Conclusions 
In this work we have leveraged high-throughput sequencing data to probe the 
binding affinity of the MTB transcriptional repressor KstR, which is a known 
mediator of a large regulon of genes involved in MTB pathogenesis. Using 
EMSAs, we have probed the in vitro binding affinity of KstR to DNA target 
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regions identified in ChiP-Seq studies, and have confirmed the rel iability of our 
ChiP-Seq data as a predictor of transcription factor binding behavior. We have 
also successfully implemented HiTS-FLIP for a single concentration of protein in 
the first such study of its kind on a Mycobacterium tuberculosis transcription 
factor. We have expanded upon the original HiTS-FLIP method by directly 
assessing a transcription factor's in vitro binding affinity against a library of its in 
vivo binding targets through the use of ChiP-Seq sequencing libraries. This work 
outlines the feasibility of an experimental framework involving ChiP-Seq followed 
by HiTS-FLIP, which can provide comprehensive in vivo and in vitro binding data 
for a transcription factor with a single sequencing run, significantly lowering the 
effective cost of each experiment. Ultimately, this method demonstrates a 
convergence of separate high-throughput transcription factor binding 
methodologies with great potential to further our understanding of bacterial 
regulatory networks in ways which were previously unimaginable. The work here 
can readily be applied to many other pathogens, and can thus increase our ability 
to understand and eradicate a host of human diseases. 
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